Seegene Inc., a pioneering in-vitro diagnostics (IVD) company in Korea, will diversify its IVD portfolio to make rapid test kits to detect not only infectious and respiratory diseases but also certain types of cancer and inherited diseases, according to the company’s R&D head.
During an interview with Maeil Business Newspaper on Thursday, Seegene’s chief technology officer Lee Min-cheol shared the company’s technology vision, saying that diagnostic kits for infectious diseases have received great attention around the world amid the coronavirus pandemic and there will be a growing demand for diagnosis of many other diseases beyond infections. Next news.
[ⓒ 매일경제 & mk.co.kr, 무단전재 및 재배포 금지]
[ⓒ Pulse by Maeil Business Newspaper & mk.co.kr, All rights reserved]